Negative SARS-CoV-2 Antibody Testing Following COVID-19 Infection in Two MS Patients Treated with Ocrelizumab

Publication date: Available online 26 June 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Jeanine Rempe Thornton, Asaff Harel
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research